Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE ALESIENNE : revenue, balance sheet and financial ratios

PHARMACIE ALESIENNE is a French company founded 3 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in ALES (30100), this company of category PME shows in 2025 a net income positive of 114 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE ALESIENNE (SIREN 949363162)
Indicator 2025 2024
Revenue N/C N/C
Net income 114 072 € 64 044 €
EBITDA N/C N/C
Net margin N/C N/C

Revenue and income statement

In 2025, PHARMACIE ALESIENNE generates positive net income of 114 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2024-2025: 64 k€ -> 114 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

114 072 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 382%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 17%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

381.957%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

17.004%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

60.0%

Solvency indicators evolution
PHARMACIE ALESIENNE

Sector positioning

Debt ratio
381.96 2025
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average

In 2025, the debt ratio of PHARMACIE ALESIENNE (381.96) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
17.0% 2025
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Watch

In 2025, the financial autonomy of PHARMACIE ALESIENNE (17.0%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 197.98. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

197.977

Liquidity indicators evolution
PHARMACIE ALESIENNE

Sector positioning

Liquidity ratio
197.98 2025
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good +7 pts over 2 years

In 2025, the liquidity ratio of PHARMACIE ALESIENNE (197.98) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positioning of PHARMACIE ALESIENNE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE ALESIENNE is estimated at 1 812 047 € (range 1 229 663€ - 2 843 351€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
1229k€ 1812k€ 2843k€
1 812 047 € Range: 1 229 663€ - 2 843 351€
NAF 5 année 2025

Valuation method used

Net Income Multiple
114 072 € × 15.9x = 1 812 047 €
Range: 1 229 664€ - 2 843 352€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE ALESIENNE with other companies in the same sector:

Frequently asked questions about PHARMACIE ALESIENNE

What is the revenue of PHARMACIE ALESIENNE ?

The revenue of PHARMACIE ALESIENNE is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE ALESIENNE profitable?

Yes, PHARMACIE ALESIENNE generated a net profit of 114 k€ in 2025.

Where is the headquarters of PHARMACIE ALESIENNE ?

The headquarters of PHARMACIE ALESIENNE is located in ALES (30100), in the department Gard.

Where to find the tax return of PHARMACIE ALESIENNE ?

The tax return of PHARMACIE ALESIENNE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE ALESIENNE operate?

PHARMACIE ALESIENNE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.